Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

JAK2 Gene Familial Thrombocytosis NGS Test in UAE | 2800 AED | 2026 DHA Guidelines

ISO 9001:2015 Certified Lab

تحليل جين JAK2 للثرومبوسايتوزيس العائلي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-accredited NGS processing, compliant with Federal Decree-Law No. 41 of 2024 and UAE PDPL data privacy standards.

Premium Logistics: Hospital-Grade Home Collection via ISO-Certified Cold-Chain Transport (8 AM–11 PM, including VIP Mobile Phlebotomy). Sample options: Whole Blood, Extracted DNA, or FTA Card.

Clinical Guidance: Telephonic Post-Test Clinical Correlation session with a DHA-licensed specialist included.

Insurance & Billing: Direct Billing Verification via WhatsApp at +971 54 548 8731. Facility License: 9834453.

الملخص التنفيذي: يضمن مختبرنا المعتمد من هيئة الصحة بدبي (ISO 9001:2015) تحليل جين JAK2 بتقنية التسلسل الجيني المتقدم بدقة تشخيصية 99.9%، مع خدمة سحب منزلي متميزة واستشارة سريرية بعد الفحص.

Test Overview

The JAK2 gene familial thrombocytosis NGS test comprehensively sequences the JAK2 gene to detect inherited and acquired mutations linked to essential thrombocythemia and other myeloproliferative neoplasms. This next-generation sequencing approach replaces older single‑mutation PCR, offering clinicians and patients in the UAE a definitive molecular diagnosis aligned with 2026 DHA precision medicine standards.

Feature Our Test (JAK2 NGS) Closest Alternative (JAK2 V617F PCR)
Precision / Sensitivity >99.9% – full gene sequencing ~95% – single hotspot only
Methodology NGS (Next‑Generation Sequencing) Allele‑Specific PCR
Turnaround Time 3–4 Weeks 1–2 Weeks
Mutations Detected V617F, exon 12, and rare variants V617F only
Price 2800 AED ~1500–2000 AED

Physician Insight & Safety Protocol

Clinical Note from Dr. PRABHAKAR REDDY, DHA License 61713011: “As a hematologist, I rely on comprehensive JAK2 NGS to differentiate familial thrombocytosis from reactive conditions and to guide prognostic discussions. A positive result must be interpreted in concert with a full blood count and bone marrow evaluation. Never alter or discontinue any prescribed medication without direct consultation with your treating physician—abrupt changes in anti‑platelet or cytoreductive therapy can carry serious thrombotic or hemorrhagic risks.”

Safety Exclusion & Emergency Flags

  • Exclusion Criteria: This genetic test is intended for individuals with persistent unexplained thrombocytosis (>450×10⁹/L), a family history of myeloproliferative neoplasms, or suspicion of JAK2 mutation‑associated disorders. It is not recommended for asymptomatic screening without clinical indication.
  • Medication Warning: Do not stop or adjust any prescribed medication before the test. Consult your doctor.
  • Urgent Red Flags: If you experience sudden chest pain, shortness of breath, severe headache, vision changes, or unilateral limb swelling, seek immediate emergency care, as these may indicate thrombotic or bleeding complications.
  • Minor Consent: In compliance with UAE CDS Law 2026, testing of minors requires legal guardian consent and paediatric haematologist referral.

Patient FAQ & Clinical Guidance

Q: What is the JAK2 gene test used for?

The JAK2 gene NGS test detects inherited and acquired mutations in the JAK2 gene that cause familial thrombocytosis and myeloproliferative neoplasms. It provides a comprehensive molecular diagnosis to guide therapy and family screening, exceeding the scope of single‑variant PCR assays.

يستخدم تحليل جين JAK2 بتقنية التسلسل الجيني المتقدم للكشف عن الطفرات الموروثة والمكتسبة في جين JAK2 المسببة للثرومبوسايتوزيس العائلي وأمراض التكاثر النقوي، مما يوفر تشخيصاً جزيئياً شاملاً لتوجيه العلاج.

Q: How is the sample collected and what options are available?

Sample collection is performed by a DHA‑licensed phlebotomist during home visit; you may provide a standard whole blood sample, pre‑extracted DNA, or a single drop of blood on an FTA card. The ISO‑certified cold‑chain transport ensures specimen integrity from collection to laboratory.

يتم سحب العينة عبر زيارة منزلية بواسطة فني معتمد من هيئة الصحة بدبي؛ ويمكن تقديم عينة دم كامل أو حمض نووي مستخلص أو قطرة دم على بطاقة FTA، مع نقل مبرد معتمد للحفاظ على جودة العينة.

Q: What is the turnaround time and total cost?

Turnaround time for the JAK2 NGS test is 3 to 4 weeks from sample receipt; the total investment is 2800 AED, inclusive of home collection, genetic counselling session, and post‑ clinical guidance. Insurance verification can be initiated via WhatsApp.

مدة صدور النتيجة تتراوح بين 3 إلى 4 أسابيع من استلام العينة، والتكلفة الكاملة 2800 درهم إماراتي تشمل السحب المنزلي وجلسة الاستشارة الوراثية والإرشاد السريري بعد النتيجة، مع إمكانية التحقق من التأمين عبر الواتساب.

Facility License No. 9834453 | ISO 9001:2015 Certificate: INT/EGQ/2509DA/3139

Compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026, and UAE PDPL

For booking: WhatsApp +971 54 548 8731

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians